Databases Company in the public registers

Neuraxpharm Slovakia, a. s.

Active

Basic details

Company ID (IČO)
35953021
Tax ID (DIČ)
2022051603
VAT ID (IČ DPH)
SK2022051603
VAT
Registered for VAT under §4 since 22/9/2005
Registered office
Sartorisova 21, 82108 Bratislava
Legal form
Akciová spoločnosť
Register entry
Obchodný register Mestského súdu Bratislava III, oddiel Sa, vložka 3682/B
Employees
5-9 zamestnancov
Established
3/9/2005

Financial data

From the financial statements in the Register of Financial Statements (RÚZ), in euros, for the last 5 years (each column is one fiscal year). Not verified; shown as the company filed them.

In 2025, Neuraxpharm Slovakia, a. s. decreased its revenue by 12% to €925,497 and made a loss of €85,177. Equity was −€949,275 and the debt ratio fell to 511.14%.

Revenue

Neuraxpharm Slovakia, a. s.

YearRevenue
2021€1,215,187
2022€1,327,907
2023€1,324,697
2024€1,048,576
2025€925,497

Profit

Neuraxpharm Slovakia, a. s.

YearProfit
2021−€104,923
2022−€129,820
2023−€137,111
2024−€277,447
2025−€85,177
2025
Revenue
€925,497
Profit
−€85,177
Assets
€230,890
Equity and liabilities
€230,890
Equity
−€949,275
Debt ratio What it shows: How much of its assets the company finances with borrowed funds.
How it is computed: (Liabilities + Accruals) / Assets
511.14%
Gross margin What it shows: The share of revenue left after the cost of goods, materials, energy and services.
How it is computed: Value added / Revenue
33.55%

Financial statements as PDF

The files open in the Register of Financial Statements (RÚZ) in a new tab.

Assets

Neuraxpharm Slovakia, a. s.

As of 31/12/2025

  • €230,890 · 100.00%

Equity and liabilities

Neuraxpharm Slovakia, a. s.

As of 31/12/2025

  • €230,890 · 100.00%

Total income

Neuraxpharm Slovakia, a. s.

YearSales of goods, products and servicesSales of fixed assets and materialOther operating incomeOther financial incomeTotal
2021€1,215,187€0−€685€2,952€1,217,454
2022€1,327,907€150€102€953€1,329,112
2023€1,324,697€232€20€22,355€1,347,304
2024€1,048,576€1,335€0€13,650€1,063,561
2025€925,497€270€0€132€925,899

Costs

Neuraxpharm Slovakia, a. s.

YearCost of goods soldMaterials and energyServicesPersonnel costsDepreciationOther operating costsFinancial costsIncome taxTotal
2021€360,001€73,217€460,433€351,991€906€46,407€29,422€0€1,322,377
2022€299,933€80,505€578,698€416,082€1,504€61,655€20,555€0€1,458,932
2023€294,946€16,239€598,255€529,852€3,403€34,428€7,292€0€1,484,415
2024€151,039€42,374€676,757€449,751€3,085€11,982€2,180€3,840€1,341,008
2025€103,240€26,964€484,766€350,966€4,564€10,833€25,903€3,840€1,011,076

Margins

Neuraxpharm Slovakia, a. s.

YearGross marginOperating marginNet margin
202126.46%−6.46%−8.63%
202227.77%−8.30%−9.78%
202331.35%−11.49%−10.35%
202417.01%−27.19%−26.46%
202533.55%−6.00%−9.20%

Year-on-year change

Neuraxpharm Slovakia, a. s.

YearRevenueProfit
2021−14%–
20229%–
20230%–
2024−21%–
2025−12%–

Financing structure

Neuraxpharm Slovakia, a. s.

YearEquityProvisionsLong-term liabilitiesShort-term liabilitiesAccruals
2021−€262,446€18,267€4,603€634,744€43,664
2022−€449,540€20,535€4,115€870,021€24,755
2023−€586,651€15,672€2,848€820,437€131,328
2024−€864,098€10,930€2,373€754,733€254,989
2025−€949,275€12,102€1,945€938,426€227,692

Income tax

Neuraxpharm Slovakia, a. s.

YearIncome taxCurrent tax
2021€0€0
2022€0€0
2023€0€0
2024€3,840€3,840
2025€3,840€3,840

Data sources

We take the data from the public registers as they publish it, unchanged and untranslated. FinPOST is an information website and does not verify the data. This page may be up to 7 days old. How we handle the data (privacy policy, section 3.9)